GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » EV-to-EBIT

Healthlead PCL (BKK:HL) EV-to-EBIT : 26.33 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Healthlead PCL EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Healthlead PCL's Enterprise Value is ฿2,713 Mil. Healthlead PCL's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ฿103 Mil. Therefore, Healthlead PCL's EV-to-EBIT for today is 26.33.

The historical rank and industry rank for Healthlead PCL's EV-to-EBIT or its related term are showing as below:

BKK:HL' s EV-to-EBIT Range Over the Past 10 Years
Min: 20.7   Med: 40.67   Max: 62.14
Current: 26.33

During the past 5 years, the highest EV-to-EBIT of Healthlead PCL was 62.14. The lowest was 20.70. And the median was 40.67.

BKK:HL's EV-to-EBIT is ranked worse than
76.54% of 81 companies
in the Medical Distribution industry
Industry Median: 12.1 vs BKK:HL: 26.33

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Healthlead PCL's Enterprise Value for the quarter that ended in Dec. 2023 was ฿2,495 Mil. Healthlead PCL's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ฿103 Mil. Healthlead PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.13%.


Healthlead PCL EV-to-EBIT Historical Data

The historical data trend for Healthlead PCL's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthlead PCL EV-to-EBIT Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - 42.23 41.77 24.22

Healthlead PCL Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.77 43.01 28.23 26.95 24.22

Competitive Comparison of Healthlead PCL's EV-to-EBIT

For the Medical Distribution subindustry, Healthlead PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthlead PCL's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Healthlead PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's EV-to-EBIT falls into.



Healthlead PCL EV-to-EBIT Calculation

Healthlead PCL's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2712.824/103.018
=26.33

Healthlead PCL's current Enterprise Value is ฿2,713 Mil.
Healthlead PCL's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healthlead PCL  (BKK:HL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Healthlead PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=103.018/2495.224
=4.13 %

Healthlead PCL's Enterprise Value for the quarter that ended in Dec. 2023 was ฿2,495 Mil.
Healthlead PCL's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healthlead PCL EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Healthlead PCL's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthlead PCL (BKK:HL) Business Description

Traded in Other Exchanges
N/A
Address
99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing innovative healthcare products.